MR Relaxation in Multiple Sclerosis

Neuroimaging Clinics of North America

Volumn 19, Issue 1, 2009, Pages 1-26

  MacKay, A L ^a,b   Vavasour, I M ^a,b   Rauscher, A ^a,b   Kolind, S H ^a,b   Madler B ^b,c   Moore, G R W ^a,b   Traboulsee, A L ^a,b   Li, D K B ^a,b   Laule, C ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c PHILIPS HEALTHCARE   (United States)

Author keywords

Brain; Multiple sclerosis; Relaxation; T1; T2

Indexed keywords

GADOLINIUM; HEME; IRON; MYELIN; WATER;

BRAIN; BRAIN WATER; COMPARATIVE STUDY; COMPREHENSION; CORRELATION ANALYSIS; EX VIVO STUDY; HISTOGRAM; HUMAN; IN VIVO STUDY; KNOWLEDGE; MEASUREMENT; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRIORITY JOURNAL; RELAXATION TIME; REVIEW; SPINAL CORD; VEIN; WATER CONTENT; WHITE MATTER;

BRAIN; BRAIN MAPPING; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; SPINAL CORD; TIME;

EID: 57049168143     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nic.2008.09.007     Document Type: Review

References (235)

1. Callaghan P.T. Principles of nuclear magnetic resonance scopy (1991), Oxford University Press, Oxford
2. Bloembergen N., Purcell E.M., and Pound R.V. Relaxation effects in nuclear magnetic resonance absorption. Physical Review 73 7 (1948) 679-712
3. Norton W., and Cammer W. Isolation and characterization of myelin. In: Morell P. (Ed). Myelin. 2nd edition (1984), Plenum Press, New York 147-195
4. Fischer H.W., Van Haverbeke Y., Schmitz-Feuerhake I., et al. The uncommon longitudinal relaxation dispersion of human brain white matter. Magn Reson Med 9 3 (1989) 441-446
5. Stewart W.A., MacKay A.L., Whittall K.P., et al. Spin-spin relaxation in experimental allergic encephalomyelitis: analysis of CPMG data using a non-linear least squares method and linear inverse theory. Magn Reson Med 29 6 (1993) 767-775
6. Bjarnason T., Vavasour I., Chia C., et al. Characterization of the NMR behaviour of white matter in bovine brain. Magn Reson Med 54 (2005) 1072-1081
7. Whittall K.P., MacKay A.L., Graeb D.A., et al. In vivo measurement of T2 distributions and water contents in normal human brain. Magn Reson Med 37 1 (1997) 34-43
8. Neeb H., Zilles K., and Shah N.J. A new method for fast quantitative mapping of absolute water content in vivo. Neuroimage 31 3 (2006) 1156-1168
9. Ye F.Q., Martin W.R., and Allen P.S. Estimation of brain iron in vivo by means of the interecho time dependence of image contrast. Magn Reson Med 36 1 (1996) 153-158
10. Schenker C., Meier D., Wichmann W., et al. Age distribution and iron dependency of the T2 relaxation time in the globus pallidus and putamen. Neuroradiology 35 2 (1993) 119-124
11. Einstein A. Motion of suspended particles in stationary liquids required from the molecular kinetic theory of heat. Annales der Physik 17 (1905) 549-560
12. Hawkins C.P., Munro P.M., MacKenzie F., et al. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain 113 Pt 2 (1990) 365-378
13. Felix R, Laniado M, Claussen C, et al. Characterization of gadolinium-DTPA: basic properties and first clinical results. Presented at the 7th Carvat. Rome, Italy, February 6-10, 1984.
14. Ge Y., Law M., Johnson G., et al. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol 26 6 (2005) 1539-1547
15. Schenck J.F. The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med Phys 23 6 (1996) 815-850
16. Schenck J.F. Safety of strong, static magnetic fields. J Magn Reson Imaging 12 1 (2000) 2-19
17. Schenck J.F., and Zimmerman E.A. High-field magnetic resonance imaging of brain iron: birth of a biomarker?. NMR Biomed 17 7 (2004) 433-445
18. Haacke E.M., Cheng N.Y.C., House M.J., et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 23 1 (2005) 1-25
19. Yablonskiy D.A., and Haacke E.M. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 32 6 (1994) 749-763
20. Pintaske J., Muller-Bierl B., and Schick F. Geometry and extension of signal voids in MR images induced by aggregations of magnetically labelled cells. Phys Med Biol 51 18 (2006) 4707-4718
21. Brown R.J.S. Distribution of fields from randomly placed dipoles: free-precession signal decay as result of magnetic grains. Physical Review 121 5 (1961) 1379-1382
22. Johnson M.A., Li D.K., Bryant D.J., et al. Magnetic resonance imaging: serial observations in multiple sclerosis. AJNR Am J Neuroradiol 5 5 (1984) 495-499
23. Sedlacik J., Rauscher A., and Reichenbach J.R. Obtaining blood oxygenation levels from MR signal behavior in the presence of single venous vessels. Magn Reson Med 58 5 (2007) 1035-1044
24. Ziener C.H., Bauer W.R., and Jakob P.M. Frequency distribution and signal formation around a vessel. MAGMA 18 4 (2005) 225-230
25. Rauscher A., Sedlacik J., Barth M., et al. Noninvasive assessment of vascular architecture and function during modulated blood oxygenation using susceptibility weighted magnetic resonance imaging. Magn Reson Med 54 1 (2005) 87-95
26. Chu S.C., Xu Y., Balschi J.A., et al. Bulk magnetic susceptibility shifts in NMR studies of compartmentalized samples: use of paramagnetic reagents. Magn Reson Med 13 2 (1990) 239-262
27. Young I.R., Cox I.J., Bryant D.J., et al. The benefits of increasing spatial resolution as a means of reducing artifacts due to field inhomogeneities. Magn Reson Imaging 6 5 (1988) 585-590
28. Haacke E.M., Tkach J.A., and Parrish T.B. Reduction of T2* dephasing in gradient field-echo imaging. Radiology 170 2 (1989) 457-462
29. Reichenbach J.R., Venkatesan R., Yablonskiy D.A., et al. Theory and application of static field inhomogeneity effects in gradient-echo imaging. J Magn Reson Imaging 7 2 (1997) 266-279
30. Ogawa S., Lee T.M., Nayak A.S., et al. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med 14 1 (1990) 68-78
31. Reichenbach J.R., and Haacke E.M. High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed 14 7-8 (2001) 453-467
32. Haacke E.M., Xu Y., Cheng Y.-C.N., et al. Susceptibility weighted imaging (SWI). Magn Reson Med 52 3 (2004) 612-618
33. Look D.C., and Locker D.R. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 41 (1970) 250-251
34. Carr H.Y., and Purcell E.M. Effects of diffusion on free precession in nuclear magnetic resonance experiments. Physical Review 94 (1954) 630-639
35. Meiboom G., and Gill D. Modified spin echo method for measuring relaxation times. Rev Sci Instrum 29 (1958) 688-691
36. Stefanovic B., and Pike G.B. Human whole-blood relaxometry at 1.5 T: assessment of diffusion and exchange models. Magn Reson Med 52 4 (2004) 716-723
37. Poon C.S., and Henkelman R.M. Practical T2 quantitation for clinical applications. J Magn Reson Imaging 2 5 (1992) 541-553
38. Vavasour I.M., Whittall K.P., Li D.K., et al. Different magnetization transfer effects exhibited by the short and long T(2) components in human brain. Magn Reson Med 44 6 (2000) 860-866
39. Oh J., Han E.T., Pelletier D., et al. Measurement of in vivo multi-component T2 relaxation times for brain tissue using multi-slice T2 prep at 1.5 and 3 T. Magn Reson Imaging 24 1 (2006) 33-43
40. Wright GA, Brittain JH, Stainsby JA. Preserving T1 or T2 contrast in magnetization preparation sequences. Presented at the 4th Annual Meeting of the International Society for Magnetic Resonance in Medicine. New York, 1996.
41. Mädler B, MacKay AL. In-vivo 3D multi-component T2-relaxation measurements for quantitative myelin imaging at 3T. Presented at the 14th Annual Meeting of the International Society of Magnetic Resonance in Medicine. Seattle, WA, 2006.
42. Mädler B, MacKay AL. Towards whole brain myelin imaging. Presented at the 15th Annual Meeting of the International Society for Magnetic Resonance in Medicine. Berlin, Germany, 2007.
43. Laule C., Vavasour I.M., Kolind S.H., et al. Long T2 water in multiple sclerosis: what else can we learn from multi-echo T2 relaxation?. J Neurol 254 11 (2007) 1579-1587
44. Graham S.J., Stanchev P.L., and Bronskill M.J. Criteria for analysis of multicomponent tissue T2 relaxation data. Magn Reson Med 35 3 (1996) 370-378
45. Whittall K.P., MacKay A.L., and Li D.K. Are mono-exponential fits to a few echoes sufficient to determine T2 relaxation for in vivo human brain?. Magn Reson Med 41 6 (1999) 1255-1257
46. Provencher S.W. A constrained regularization method for inverting data represented by linear algebraic or integral equations. Comput Phys Commun 27 (1982) 213-227
47. Whittall K.P., and MacKay A.L. Quantitative interpretation of NMR relaxation data. J Magn Reson 84 (1989) 134-152
48. Fenrich F.R., Beaulieu C., and Allen P.S. Relaxation times and structures. NMR Biomed 14 2 (2001) 133-139
49. Kroeker R.M., and Henkelman R.M. Analysis of biological NMR relaxation data with continuous distributions of relaxation times. J Magn Reson 69 (1986) 218-235
50. Henkelman R.M. Measurement of signal intensities in the presence of noise in MR images. Med Phys 12 2 (1985) 232-233
51. Webb S., Munro C.A., Midha R., et al. Is multicomponent T2 a good measure of myelin content in peripheral nerve?. Magn Reson Med 49 4 (2003) 638-645
52. Gareau P.J., Rutt B.K., Karlik S.J., et al. Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J Magn Reson Imaging 11 6 (2000) 586-595
53. Beaulieu C., Fenrich F.R., and Allen P.S. Multicomponent water proton transverse relaxation and T2-discriminated water diffusion in myelinated and nonmyelinated nerve. Magn Reson Imaging 16 10 (1998) 1201-1210
54. Tozer D.J., Davies G.R., Altmann D.R., et al. Correlation of apparent myelin measures obtained in multiple sclerosis patients and controls from magnetization transfer and multicompartmental T2 analysis. Magn Reson Med 53 6 (2005) 1415-1422
55. Lawson C.L., and Hanson R.J. Solving least squares problems (1974), Prentice-Hall, Englewood Cliffs (NJ)
56. Armspach J.P., Gounot D., Rumbach L., et al. In vivo determination of multiexponential T2 relaxation in the brain of patients with multiple sclerosis. Magn Reson Imaging 9 1 (1991) 107-113
57. Lancaster J.L., Andrews T., Hardies L.J., et al. Three-pool model of white matter. J Magn Reson Imaging 17 1 (2003) 1-10
58. Vermathen P., Robert-Tissot L., Pietz J., et al. Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging. Magn Reson Med 58 6 (2007) 1145-1156
59. Du Y.P., Chu R., Hwang D., et al. Fast multislice mapping of the myelin water fraction using multicompartment analysis of T2* decay at 3T: a preliminary postmortem study. Magn Reson Med 58 5 (2007) 865-870
60. Deoni SC, Rutt BK, Arun T, et al. Gleaning multi-component T1 and T2 information from steady-state imaging data. Presented at the 16th Annual Meeting of the International Society for Magnetic Resonance in Medicine. Toronto, Canada, 2008.
61. Frahm J., Merboldt K.D., and Hanicke W. Direct FLASH MR imaging of magnetic field inhomogeneities by gradient compensation. Magn Reson Med 6 4 (1988) 474-480
62. Fernandez-Seara M.A., and Wehrli F.W. Postprocessing technique to correct for background gradients in image-based R*(2) measurements. Magn Reson Med 44 3 (2000) 358-366
63. Dahnke H., and Schaeffter T. Limits of detection of SPIO at 3.0 T using T2 relaxometry. Magn Reson Med 53 5 (2005) 1202-1206
64. Kiselev V.G. Effect of magnetic field gradients induced by vasculature on NMR measurements of molecular self-diffusion in biological tissues. J Magn Reson 170 2 (2004) 228-235
65. Yablonskiy D.A. Quantitation of intrinsic magnetic susceptibility-related effects in a tissue matrix: phantom study. Magn Reson Med 39 3 (1998) 417-428
66. Conturo T.E., and Smith G.D. Signal-to-noise in phase angle reconstruction: dynamic range extension using phase reference offsets. Magn Reson Med 15 3 (1990) 420-437
67. Witoszynskyj S, Rauscher A, Reichenbach JR, et al. Phase unwrapping of MR images using [Phi]UN - A fast and robust region growing algorithm. Medical Image Analysis, in press.
68. Rauscher A., Barth M., Reichenbach J.R., et al. Automated unwrapping of MR phase images applied to BOLD MR-venography at 3 Tesla. J Magn Reson Imaging 18 2 (2003) 175-180
69. Jenkinson M., Bannister P., Brady M., et al. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17 2 (2002) 825-841
70. Chavez S., Xiang Q.S., and An L. Understanding phase maps in MRI: a new cutline phase unwrapping method. IEEE Trans Med Imaging 21 8 (2002) 966-977
71. Kamman R.L., Go K.G., Brouwer W., et al. Nuclear magnetic resonance relaxation in experimental brain edema: effects of water concentration, protein concentration, and temperature. Magn Reson Med 6 3 (1988) 265-274
72. Fatouros P.P., and Marmarou A. Experimental studies for use of magnetic resonance in brain water measurements. Acta Neurochir Suppl 51 (1990) 37-38
73. Fatouros P.P., Marmarou A., Kraft K.A., et al. In vivo brain water determination by T1 measurements: effect of total water content, hydration fraction, and field strength. Magn Reson Med 17 2 (1991) 402-413
74. Kamman R.L., Go K.G., Stomp G.P., et al. Changes of relaxation times T1 and T2 in rat tissues after biopsy and fixation. Magn Reson Imaging 3 3 (1985) 245-250
75. MacDonald H.L., Bell B.A., Smith M.A., et al. Correlation of human NMR T1 values measured in vivo and brain water content. Br J Radiol 59 700 (1986) 355-357
76. Koenig S.H., Brown III R.D., Spiller M., et al. Relaxometry of brain: why white matter appears bright in MRI. Magn Reson Med 14 3 (1990) 482-495
77. Fatouros P.P., and Marmarou A. Use of magnetic resonance imaging for in vivo measurements of water content in human brain: method and normal values. J Neurosurg 90 1 (1999) 109-115
78. Naruse S., Horikawa Y., Tanaka C., et al. Significance of proton relaxation time measurement in brain oedema, cerebral infarction and brain tumors. Magn Reson Med 4 (1986) 293-304
79. Rooney W.D., Johnson G., Li X., et al. Magnetic field and tissue dependencies of human brain longitudinal 1H2O relaxation in vivo. Magn Reson Med 57 2 (2007) 308-318
80. Gelman N., Ewing J.R., Gorell J.M., et al. Interregional variation of longitudinal relaxation rates in human brain at 3.0 T: relation to estimated iron and water contents. Magn Reson Med 45 1 (2001) 71-79
81. Prantner A, Bretthorst G, Neil J, et al. Tissue (brain) water longitudinal relaxation is biexponential. Presented at the 16th Annual Meeting of the International Society for Magnetic Resonance in Medicine. Toronto, Canada, 2008.
82. Labadie C, Lee J-H, Jarchow S, et al. Detection of the myelin water fraction in 4 Tesla longitudinal relaxation data by cross-regularised inverse Laplace transform. Presented at the 16th Annual Meeting of the International Society for Magnetic Resonance in Medicine. Toronto, Canada, 2008.
83. In: Tofts P.S. (Ed). Quantitative MRI of the brain: measuring changes caused by disease (2003), Wiley, Chichester West Sussex 316
84. Swift T.J., and Fritz Jr. O.G. A proton spin-echo study of the state of water in frog nerves. Biophys J 9 1 (1969) 54-59
85. Vasilescu V., Katona E., Simplaceanu V., et al. Water compartments in the myelinated nerve. III. Pulsed NMR results. Experientia 34 11 (1978) 1443-1444
86. Menon R.S., and Allen P.S. Application of continuous relaxation time distributions to the fitting of data from model systems and excised tissue. Magn Reson Med 20 2 (1991) 214-227
87. Does M.D., and Snyder R.E. T2 relaxation of peripheral nerve measured in vivo. Magn Reson Imaging 13 4 (1995) 575-580
88. MacKay A., Whittall K., Adler J., et al. In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med 31 6 (1994) 673-677
89. Laule C., Leung E., Lis D.K., et al. Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology. Mult Scler 12 6 (2006) 747-753
90. Laule C., Kozlowski P., Leung E., et al. Myelin water imaging of multiple sclerosis at 7 T: correlations with histopathology. Neuroimage 40 (2008) 1575-1580
91. Wu Y., Alexander A.L., Fleming J.O., et al. Myelin water fraction in human cervical spinal cord in vivo. J Comput Assist Tomogr 30 2 (2006) 304-306
92. Minty E, MacKay A, Whittall KP. Measurement of myelin water in human and bovine spinal cord. Presented at the 10th Annual Meeting of the International Society of Magnetic Resonance in Medicine. Honolulu, HI, 2002.
93. Laule C, Vavasour IM, Vavasour JD, et al. Cervical cord abnormalities in primary progressive multiple sclerosis: atrophy and myelin water changes. Presented at the 12th Meeting of the International Society of Magnetic Resonance in Medicine. Kyoto, Japan, 2004.
94. MacMillan EL, Curt A, Maedler B, et al. 3D myelin water imaging of cervical spondylotic myelopathy at 3T. Presented at the 16th Annual Meeting of the International Society for Magnetic Resonance in Medicine. Toronto, Canada, 2008.
95. Jones C.K., Xiang Q.S., Whittall K.P., et al. Linear combination of multiecho data: short T2 component selection. Magn Reson Med 51 3 (2004) 495-502
96. Vidarsson L., Conolly S.M., Lim K.O., et al. Echo time optimization for linear combination myelin imaging. Magn Reson Med 53 2 (2005) 398-407
97. Stanisz G.J., Kecojevic A., Bronskill M.J., et al. Characterizing white matter with magnetization transfer and T(2). Magn Reson Med 42 6 (1999) 1128-1136
98. Harrison R., Bronskill M.J., and Henkelman R.M. Magnetization transfer and T2 relaxation components in tissue. Magn Reson Med 33 4 (1995) 490-496
99. Peters A.M., Brookes M.J., Hoogenraad F.G., et al. T2* measurements in human brain at 1.5, 3 and 7 T. Magn Reson Imaging 25 6 (2007) 748-753
100. Silvennoinen M.J., Clingman C.S., Golay X., et al. Comparison of the dependence of blood R2 and R2* on oxygen saturation at 1.5 and 4.7 Tesla. Magn Reson Med 49 1 (2003) 47-60
101. Zhao J.M., Clingman C.S., Narvainen M.J., et al. Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3T. Magn Reson Med 58 3 (2007) 592-597
102. Koopmans P.J., Manniesing R., Niessen W.J., et al. MR venography of the human brain using susceptibility weighted imaging at very high field strength. MAGMA 21 1-2 (2008) 149-158
103. Norris D.G. Principles of magnetic resonance assessment of brain function. J Magn Reson Imaging 23 6 (2006) 794-807
104. Meindl T., Born C., Britsch S., et al. Functional BOLD MRI: comparison of different field strengths in a motor task. Eur Radiol 18 6 (2008) 1102-1113
105. Reichenbach J.R., Essig M., Haacke E.M., et al. High-resolution venography of the brain using magnetic resonance imaging. MAGMA 6 1 (1998) 62-69
106. Haacke E.M., Xu Y., Cheng Y.C., et al. Susceptibility weighted imaging (SWI). Magn Reson Med 52 3 (2004) 612-618
107. Xu Y., and Haacke E.M. The role of voxel aspect ratio in determining apparent vascular phase behavior in susceptibility weighted imaging. Magn Reson Imaging 24 2 (2006) 155-160
108. Lin W., Mukherjee P., An H., et al. Improving high-resolution MR bold venographic imaging using a T1 reducing contrast agent. J Magn Reson Imaging 10 2 (1999) 118-123
109. Reichenbach J.R., Barth M., Haacke E.M., et al. High-resolution MR venography at 3.0 Tesla. J Comput Assist Tomogr 24 6 (2000) 949-957
110. Hoogenraad F.G., Reichenbach J.R., Haacke E.M., et al. In vivo measurement of changes in venous blood-oxygenation with high resolution functional MRI at 0.95 Tesla by measuring changes in susceptibility and velocity. Magn Reson Med 39 1 (1998) 97-107
111. Barth M., Reichenbach J.R., Venkatesan R., et al. High-resolution, multiple gradient-echo functional MRI at 1.5 T. Magn Reson Imaging 17 3 (1999) 321-329
112. Barth M., and Norris D.G. Very high-resolution three-dimensional functional MRI of the human visual cortex with elimination of large venous vessels. NMR Biomed 20 5 (2007) 477-484
113. Young I.R., Khenia S., Thomas D.G., et al. Clinical magnetic susceptibility mapping of the brain. J Comput Assist Tomogr 11 1 (1987) 2-6
114. Yamada N., Imakita S., Sakuma T., et al. Evaluation of the susceptibility effect on the phase images of a simple gradient echo. Radiology 175 2 (1990) 561-565
115. Rauscher A., Sedlacik J., Barth M., et al. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol 26 4 (2005) 736-742
116. Deistung A., Mentzel H.-J., Rauscher A., et al. Demonstration of paramagnetic and diamagnetic cerebral lesions by using susceptibility weighted phase imaging (SWI). Z Med Phys 16 4 (2006) 261-267
117. Deistung A., Rauscher A., Sedlacik J., et al. Informatics in radiology. GUIBOLD: a graphical user interface for image reconstruction and data analysis in susceptibility-weighted MR imaging. Radiographics 28 3 (2008) 639-651
118. Duyn J.H., van Gelderen P., Li T.-Q., et al. High-field MRI of brain cortical substructure based on signal phase. Proc Natl Acad Sci USA 104 28 (2007) 11796-11801
119. Ogg R.J., Langston J.W., Haacke E.M., et al. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging 17 8 (1999) 1141-1148
120. Hallgren B., and Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 3 (1958) 41-51
121. Haacke E.M., Ayaz M., Khan A., et al. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging 26 2 (2007) 256-264
122. Xu X., Wang Q., and Zhang M. Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study. Neuroimage 40 1 (2008) 35-42
123. Zhong K., Leupold J., von Elverfeldt D., et al. The molecular basis for gray and white matter contrast in phase imaging. Neuroimage 40 4 (2008) 1561-1566
124. Ormerod I.E.C., Bronstein A., Rudge P., et al. Magnetic resonance imaging in clinically isolated lesions of the brain stem. J Neurol Neurosurg Psychiatry 49 (1986) 737-743
125. Larsson H.B., Frederiksen J., Petersen J., et al. Assessment of demyelination, edema, and gliosis by in vivo determination of T1 and T2 in the brain of patients with acute attack of multiple sclerosis. Magn Reson Med 11 3 (1989) 337-348
126. Larsson H.B., Frederiksen J., Kjaer L., et al. In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis. Magn Reson Med 7 1 (1988) 43-55
127. Vavasour I.M., Li D.K., Laule C., et al. Multi-parametric MR assessment of T(1) black holes in multiple sclerosis: evidence that myelin loss is not greater in hypointense versus isointense T(1) lesions. J Neurol 254 12 (2007) 1653-1659
128. Vavasour IM, Li DKB, Laule C, et al. Myelin water is an independent measure of pathology in multiple sclerosis. Presented at ISMRM. Seattle, WA, 2006.
129. Stevenson V.L., Parker G.J., Barker G.J., et al. Variations in T1 and T2 relaxation times of normal appearing white matter and lesions in multiple sclerosis. J Neurol Sci. 178 2 (2000) 81-87
130. Truyen L., van Waesberghe J.H., van Walderveen M.A., et al. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 47 6 (1996) 1469-1476
131. McDonald W.I., Miller D.H., and Thompson A.J. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta. Ann Neurol 36 1 (1994) 14-18
132. Miki Y., Grossman R.I., Udupa J.K., et al. Relapsing-remitting multiple sclerosis: longitudinal analysis of MR images. Lack of correlation between changes in T2 lesion volume and clinical findings. Radiology 213 2 (1999) 395-399
133. van Walderveen M.A., Barkhof F., Hommes O.R., et al. Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology 45 9 (1995) 1684-1690
134. Cid C., Alcazar A., Regidor I., et al. Neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients correlates with hypointense lesions on T1 magnetic resonance imaging. J Neurol Sci 193 2 (2002) 103-109
135. Sailer M., Losseff N.A., Wang L., et al. T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis: a prospective 18 months follow-up study. Eur J Neurol 8 1 (2001) 37-42
136. Simon J.H., Lull J., Jacobs L.D., et al., Multiple Sclerosis Collaborative Research Group. A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Neurology 55 2 (2000) 185-192
137. van Walderveen M.A., Lycklama A.N.G.J., Ader H.J., et al. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. Arch Neurol 58 1 (2001) 76-81
138. Bagnato F., Jeffries N., Richert N.D., et al. Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain 126 Pt 8 (2003) 1782-1789
139. van Walderveen M.A., Barkhof F., Pouwels P.J., et al. Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy. Ann Neurol 46 1 (1999) 79-87
140. Li B.S., Regal J., Soher B.J., et al. Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 24 1 (2003) 68-74
141. Nusbaum A.O., Lu D., Tang C.Y., et al. Quantitative diffusion measurements in focal multiple sclerosis lesions: correlations with appearance on TI-weighted MR images. AJR Am J Roentgenol 175 3 (2000) 821-825
142. Nusbaum A.O., Tang C.Y., Wei T.C., et al. Whole-brain diffusion MR histograms differ between MS subtypes. Neurology 54 7 (2000) 1421-1427
143. Droogan A.G., Clark C.A., Werring D.J., et al. Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging. Magn Reson Imaging 17 5 (1999) 653-661
144. Castriota-Scanderbeg A., Fasano F., Hagberg G., et al. Coefficient D(av) is more sensitive than fractional anisotropy in monitoring progression of irreversible tissue damage in focal nonactive multiple sclerosis lesions. AJNR Am J Neuroradiol 24 4 (2003) 663-670
145. Brück W., Bitsch A., Kolenda H., et al. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 42 5 (1997) 783-793
146. van Walderveen M.A., Kamphorst W., Scheltens P., et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 50 5 (1998) 1282-1288
147. van Waesberghe J.H., Kamphorst W., De Groot C.J., et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46 5 (1999) 747-754
148. Bitsch A., Kuhlmann T., Stadelmann C., et al. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol 49 6 (2001) 793-796
149. Haughton V.M., Yetkin F.Z., Rao S.M., et al. Quantitative MR in the diagnosis of multiple sclerosis. Magn Reson Med 26 1 (1992) 71-78
150. Miller D.H., Johnson G., Tofts P.S., et al. Precise relaxation time measurements of normal-appearing white matter in inflammatory central nervous system disease. Magn Reson Med 11 3 (1989) 331-336
151. Brainin M., Neuhold A., Reisner T., et al. Changes within the "normal" cerebral white matter of multiple sclerosis patients during acute attacks and during high-dose cortisone therapy assessed by means of quantitative MRI. J Neurol Neurosurg Psychiatr 52 12 (1989) 1355-1359
152. Lacomis D., Osbakken M., and Gross G. Spin-lattice relaxation (T1) times of cerebral white matter in multiple sclerosis. Magn Reson Med 3 2 (1986) 194-202
153. Kesselring J., Miller D.H., MacManus D.G., et al. Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone. J Neurol Neurosurg Psychiatr 52 1 (1989) 14-17
154. Barbosa S., Blumhardt L.D., Roberts N., et al. Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the "invisible" lesion load. Magn Reson Imaging 12 1 (1994) 33-42
155. Castriota-Scanderbeg A., Fasano F., Filippi M., et al. T1 relaxation maps allow differentiation between pathologic tissue subsets in relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler 10 5 (2004) 556-561
156. Davies G.R., Hadjiprocopis A., Altmann D.R., et al. Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal study. Mult Scler 13 2 (2007) 169-177
157. Parry A., Clare S., Jenkinson M., et al. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis. J Neurol 249 9 (2002) 1279-1286
158. Srinivasan R., Henry R., Pelletier D., et al. Standardized, reproducible, high resolution global measurements of T1 relaxation metrics in cases of multiple sclerosis. AJNR Am J Neuroradiol 24 1 (2003) 58-67
159. Vrenken H., Geurts J.J., Knol D.L., et al. Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology 240 3 (2006) 811-820
160. Vrenken H., Rombouts S.A., Pouwels P.J., et al. Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter. AJNR Am J Neuroradiol 27 4 (2006) 868-874
161. Barkhof F. Whole-brain T1-relaxation time measurements in multiple sclerosis. J Neurol 249 10 (2002) 1451-1452
162. van Walderveen M.A., van Schijndel R.A., Pouwels P.J., et al. Multislice T1 relaxation time measurements in the brain using IR-EPI: reproducibility, normal values, and histogram analysis in patients with multiple sclerosis. J Magn Reson Imaging 18 6 (2003) 656-664
163. Parry A., Clare S., Jenkinson M., et al. MRI brain T1 relaxation time changes in MS patients increase over time in both the white matter and the cortex. J Neuroimaging 13 3 (2003) 234-239
164. Manfredonia F., Ciccarelli O., Khaleeli Z., et al. Normal-appearing brain T1 relaxation time predicts disability in early primary progressive multiple sclerosis. Arch Neurol 64 3 (2007) 411-415
165. Vrenken H., Geurts J.J., Knol D.L., et al. Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis. AJNR Am J Neuroradiol 27 9 (2006) 2005-2011
166. Vaithianathar L., Tench C.R., Morgan P.S., et al. T1 relaxation time mapping of white matter tracts in multiple sclerosis defined by diffusion tensor imaging. J Neurol 249 9 (2002) 1272-1278
167. Vaithianathar L., Tench C.R., Morgan P.S., et al. White matter T(1) relaxation time histograms and cerebral atrophy in multiple sclerosis. J Neurol Sci 197 1-2 (2002) 45-50
168. Brex P.A., Parker G.J., Leary S.M., et al. Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations. J Neurol Neurosurg Psychiatr 68 5 (2000) 627-632
169. Vaithianathar L., Tench C.R., Morgan P.S., et al. Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis-a quantitative T1 relaxation time mapping approach. J Neurol 250 3 (2003) 307-315
170. Mottershead J.P., Schmierer K., Clemence M., et al. High field MRI correlates of myelin content and axonal density in multiple sclerosis: a post-mortem study of the spinal cord. J Neurol 250 11 (2003) 1293-1301
171. Goodkin D.E., Rooney W.D., Sloan R., et al. A serial study of new MS lesions and the white matter from which they arise. Neurology 51 6 (1998) 1689-1697
172. Vavasour IM, MacKay AL, Whittall KP, et al. A serial magnetic resonance study of multiple sclerosis: T2 relaxation, T1 relaxation and magnetization transfer. Presented at the 51st Annual Meeting of the American Academy of Neurology. Toronto, Canada, 1999.
173. Barnes D., Munro P.M., Youl B.D., et al. The longstanding MS lesion: a quantitative MRI and electron microscopic study. Brain 114 Pt 3 (1991) 1271-1280
174. Papanikolaou N., Papadaki E., Karampekios S., et al. T2 relaxation time analysis in patients with multiple sclerosis: correlation with magnetization transfer ratio. Eur Radiol 14 1 (2004) 115-122
175. Filippi M., Barker G.J., Horsfield M.A., et al. Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study. J Neurol 241 (1994) 246-251
176. Kidd D., Barker G.J., Tofts P.S., et al. The transverse magnetisation decay characteristics of longstanding lesions and normal-appearing white matter in multiple sclerosis. J Neurol 244 2 (1997) 125-130
177. Laule C., Vavasour I.M., Moore G.R.W., et al. Water content and myelin water fraction in multiple sclerosis: a T2 relaxation study. J Neurol 251 3 (2004) 284-293
178. Oh J., Han E.T., Lee M.C., et al. Multislice brain myelin water fractions at 3T in multiple sclerosis. J Neuroimaging 17 2 (2007) 156-163
179. Whittall K.P., MacKay A.L., Li D.K., et al. Normal-appearing white matter in multiple sclerosis has heterogeneous, diffusely prolonged T(2). Magn Reson Med 47 2 (2002) 403-408
180. Grenier D., Pelletier D., Normandeau M., et al. T2 relaxation time histograms in multiple sclerosis. Magn Reson Imaging 20 10 (2002) 733-741
181. Filippi M., Rocca M.A., Martino G., et al. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 43 6 (1998) 809-814
182. Pike G.B., De Stefano N., Narayanan S., et al. Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Radiology 215 3 (2000) 824-830
183. Richert N.D., Ostuni J.L., Bash C.N., et al. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis. Mult Scler 7 1 (2001) 49-58
184. Narayana P.A., Doyle T.J., Lai D., et al. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 43 1 (1998) 56-71
185. Werring D.J., Brassat D., Droogan A.G., et al. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain 123 Pt 8 (2000) 1667-1676
186. Moore G.R.W., Leung E., MacKay A.L., et al. A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain. Neurology 55 10 (2000) 1506-1510
187. Ramani A., Aliev A.E., Barker G.J., et al. Another approach to protons with constricted mobility in white matter: pilot studies using wideline and high-resolution NMR spectroscopy. Magn Reson Imaging 21 9 (2003) 1039-1043
188. Tan I.L., van Schijndel R.A., Pouwels P.J., et al. MR venography of multiple sclerosis. AJNR Am J Neuroradiol 21 6 (2000) 1039-1042
189. Dixon J, Tallantyre E, Morgan PS, et al. Susceptibility-weighted MR imaging of vascular distribution in white-matter MS lesions. Presented at the 16th Annual Meeting of the International Society for Magnetic Resonance in Medicine. Toronto, Canada, 2008.
190. Haacke EM, Makki M, Ge Y, et al. Correlating iron with T2 signal intensity in multiple sclerosis lesions using susceptibility weighted imaging. Presented at the 16th Annual Meeting of the International Society for Magnetic Resonance in Medicine. Toronto, Canada, 2008.
191. Eissa A, Lebel R, Korzan J, et al. MRI of multiple sclerosis with high contrast susceptibility-weighting and extreme resolution T2-weighting. Presented at the 16th Annual Meeting of the International Society for Magnetic Resonance in Medicine. Toronto, Canada, 2008.
192. Hammond K.E., Lupo J.M., Xu D., et al. Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage 39 4 (2008) 1682-1692
193. Shah J, Rammohan K, Racke M, et al. New approaches for ms lesion characterization with ultrahigh field MSRI: comparison of T2*/phase susceptibility weighted images with T2- and inversion recovery fast spin echo sequences. Presented at the 16th Annual Meeting of the International Society for Magnetic Resonance in Medicine. Toronto, Canada, 2008.
194. Pantano P., Mainero C., and Caramia F. Functional brain reorganization in multiple sclerosis: evidence from fMRI studies. J Neuroimaging 16 2 (2006) 104-114
195. Buckle G.J. Functional magnetic resonance imaging and multiple sclerosis: the evidence for neuronal plasticity. J Neuroimaging 15 4 Suppl (2005) 82s-93s
196. Rocca M.A., and Filippi M. Functional MRI in multiple sclerosis. J Neuroimaging 17 Suppl 1 (2007) 36s-41s
197. Strijkers G.J., Mulder W.J., van Tilborg G.A., et al. MRI contrast agents: current status and future perspectives. Anticancer Agents Med Chem 7 3 (2007) 291-305
198. Sibson N.R., Blamire A.M., Bernades-Silva M., et al. MRI detection of early endothelial activation in brain inflammation. Magn Reson Med 51 2 (2004) 248-252
199. Wessig C., Bendszus M., and Stoll G. In vivo visualization of focal demyelination in peripheral nerves by gadofluorine M-enhanced magnetic resonance imaging. Exp Neurol 204 1 (2007) 14-19
200. Vellinga M.M., Oude Engberink R.D., Seewann A., et al. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain 131 Pt 3 (2008) 800-807
201. Dousset V., Brochet B., Deloire M.S., et al. MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. AJNR Am J Neuroradiol 27 5 (2006) 1000-1005
202. Oweida A.J., Dunn E.A., Karlik S.J., et al. Iron-oxide labeling of hematogenous macrophages in a model of experimental autoimmune encephalomyelitis and the contribution to signal loss in fast imaging employing steady state acquisition (FIESTA) images. J Magn Reson Imaging 26 1 (2007) 144-151
203. Brochet B., Deloire M.S., Touil T., et al. Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE. Neuroimage 32 1 (2006) 266-274
204. Heyn C., Ronald J.A., Mackenzie L.T., et al. In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magn Reson Med 55 1 (2006) 23-29
205. Anderson S.A., Shukaliak-Quandt J., Jordan E.K., et al. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol 55 5 (2004) 654-659
206. Frank J.A., Miller B.R., Arbab A.S., et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 228 2 (2003) 480-487
207. Moseley M.E., Cohen Y., Kucharczyk J., et al. Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology 176 2 (1990) 439-445
208. Thomsen C., Henriksen O., and Ring P. In vivo measurement of water self diffusion in the human brain by magnetic resonance imaging. Acta Radiol 28 3 (1987) 353-361
209. Basser P.J. Inferring structural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed 8 7-8 (1995) 333-344
210. Basser P.J., and Pajevic S. Statistical artifacts in diffusion tensor MRI (DT-MRI) caused by background noise. Magn Reson Med 44 1 (2000) 41-50
211. Xue R., van Zijl P.C.M., Crain B.J., et al. In vivo three-dimensional reconstruction of rat brain axonal projections by diffusion tensor imaging. Magn Reson Med 42 6 (1999) 1123-1127
212. Beaulieu C., Does M.D., Snyder R.E., et al. Changes in water diffusion due to Wallerian degeneration in peripheral nerve. Magn Reson Med 36 4 (1996) 627-631
213. Biton I.E., Duncan I.D., and Cohen Y. High b-value q-space diffusion MRI in myelin-deficient rat spinal cords. Magn Reson Imaging 24 2 (2006) 161-166 Epub 2005 Dec 2027
214. Kim J.H., Budde M.D., Liang H.F., et al. Detecting axon damage in spinal cord from a mouse model of multiple sclerosis. Neurobiol Dis 21 3 (2006) 626-632 Epub 2005 Nov 2017
215. Song S.K., Sun S.W., Ju W.K., et al. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 20 3 (2003) 1714-1722
216. Song S.K., Sun S.W., Ramsbottom M.J., et al. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17 3 (2002) 1429-1436
217. Song S.K., Yoshino J., Le T.Q., et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 26 1 (2005) 132-140
218. Sun S.W., Liang H.F., Le T.Q., et al. Differential sensitivity of in vivo and ex vivo diffusion tensor imaging to evolving optic nerve injury in mice with retinal ischemia. Neuroimage 32 3 (2006) 1195-1204 Epub 2006 Jun 1122
219. Sun S.W., Liang H.F., Trinkaus K., et al. Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn Reson Med 55 2 (2006) 302-308
220. Thomalla G., Glauche V., Koch M.A., et al. Diffusion tensor imaging detects early Wallerian degeneration of the pyramidal tract after ischemic stroke. Neuroimage 22 4 (2004) 1767-1774
221. Mädler B., Drabycz S.A., Kolind S.H., et al. Is diffusion anisotropy an accurate monitor of myelination? Correlation of multicomponent T2 relaxation and diffusion tensor anisotropy in human brain. Magn Reson Imaging 26 7 (2008) 874-888
222. Bells S, Morris D, Vidarsson L. Comparison of linear combination filtering to DTI and MTR in whole brain myelin-water imaging. Presented at the 15th Annual Meeting of the International Society of Magnetic Resonance in Medicine. Berlin, Germany, 2007.
223. Beaulieu C. The basis of anisotropic water diffusion in the nervous system: a technical review. NMR Biomed 15 7-8 (2002) 435-455
224. Kolind S.H., Laule C., Vavasour I.M., et al. Complementary information from multi-exponential T(2) relaxation and diffusion tensor imaging reveals differences between multiple sclerosis lesions. Neuroimage 40 1 (2008) 77-85
225. Tyszka J.M., Readhead C., Bearer E.L., et al. Statistical diffusion tensor histology reveals regional dysmyelination effects in the shiverer mouse mutant. Neuroimage 29 4 (2006) 1058-1065
226. Wu Y-C, Alexander AL, Duncan ID, et al. Hybrid diffusion imaging in a brain model of dysmyelination. Presented at the 15th Annual Meeting of the International Society of Magnetic Resonance in Medicine. Berlin, Germany, 2007.
227. van Waesberghe J.H., Castelijns J.A., Scheltens P., et al. Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions. Magn Reson Imaging 15 2 (1997) 155-162
228. Griffin C.M., Parker G.J., Barker G.J., et al. MTR and T1 provide complementary information in MS NAWM, but not in lesions. Mult Scler 6 5 (2000) 327-331
229. Schmierer K., Scaravilli F., Altmann D.R., et al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 56 3 (2004) 407-415
230. Karampekios S., Papanikolaou N., Papadaki E., et al. Quantification of magnetization transfer rate and native T1 relaxation time of the brain: correlation with magnetization transfer ratio measurements in patients with multiple sclerosis. Neuroradiology 47 3 (2005) 189-196
231. Vavasour I.M. Magnetic resonance of human and bovine brain [doctoral thesis] (1998), University of British Columbia, Vancouver
232. Papanikolaou N., Maniatis V., Pappas J., et al. Biexponential T2 relaxation time analysis of the brain: correlation with magnetization transfer ratio. Invest Radiol 37 7 (2002) 363-367
233. Wu Y, Field A, Alexander A, et al. Quantification of myelin water in human cervical spinal cord in vivo. Presented at the 12th Annual Meeting of the International Society for Magnetic Resonance in Medicine. Kyoto, Japan, 2004.
234. Helms G., and Piringer A. Magnetization transfer of water T(2) relaxation components in human brain: implications for T(2)-based segmentation of spectroscopic volumes. Magn Reson Imaging 19 6 (2001) 803-811
235. Morrissey S.P., Stodal H., Zettl U., et al. In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis: quantification of inflammation and oedema. Brain 119 Pt 1 (1996) 239-248